AI reveals novel cellular hallmarks of Parkinson’s disease
A study was recently published in Nature Communications that presents a novel automated cell culture platform, which researchers utilized to uncover previously unknown cellular signatures of Parkinson’s disease. The researchers suggest this could be employed to discover more effective drugs for a range of diseases.
The platform utilizes artificial intelligence (AI) technology to study images of patient cells. Scientists from the New York Stem Cell Foundation (NYSCF; NY, USA) reported that they have identified the specific cellular hallmarks of Parkinson’s disease, which could be utilized to discover better treatment for the condition.
